Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-10-18

FDA Approved: OPSUMIT — Original Application (Actelion Pharmaceuticals US, Inc.)

View source ↗

Summary

FDA approved OPSUMIT (macitentan) under the original application, for the treatment of pulmonary arterial hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OPSUMIT (macitentan)

Snippet

ORIG AP for OPSUMIT (MACITENTAN)